Annual Current Liabilities
$45.94 M
-$9.61 M-17.30%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual total current liabilities is $45.94 million, with the most recent change of -$9.61 million (-17.30%) on December 31, 2023.
- During the last 3 years, TNGX annual current liabilities has risen by +$5.02 million (+12.27%).
- TNGX annual current liabilities is now -17.30% below its all-time high of $55.55 million, reached on December 31, 2022.
Performance
TNGX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$37.58 M
-$6.29 M-14.33%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly total current liabilities is $37.58 million, with the most recent change of -$6.29 million (-14.33%) on September 30, 2024.
- Over the past year, TNGX quarterly current liabilities has dropped by -$8.36 million (-18.19%).
- TNGX quarterly current liabilities is now -32.34% below its all-time high of $55.55 million, reached on December 31, 2022.
Performance
TNGX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TNGX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.3% | -18.2% |
| 3 y3 years | +12.3% | -30.0% |
| 5 y5 years | +12.3% | -30.0% |
TNGX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.3% | +12.9% | -32.3% | at low |
| 5 y | 5-year | -17.3% | +12.9% | -32.3% | at low |
| alltime | all time | -17.3% | +12.9% | -32.3% | at low |
Tango Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.58 M(-14.3%) |
| Jun 2024 | - | $43.87 M(+2.5%) |
| Mar 2024 | - | $42.79 M(-6.9%) |
| Dec 2023 | $45.94 M(-17.3%) | $45.94 M(+5.8%) |
| Sep 2023 | - | $43.42 M(-19.0%) |
| Jun 2023 | - | $53.63 M(-0.1%) |
| Mar 2023 | - | $53.67 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $55.55 M(+36.5%) | $55.55 M(+8.2%) |
| Sep 2022 | - | $51.32 M(+14.9%) |
| Jun 2022 | - | $44.68 M(+14.0%) |
| Mar 2022 | - | $39.21 M(-3.6%) |
| Dec 2021 | $40.69 M(-0.6%) | $40.69 M(-3.1%) |
| Sep 2021 | - | $41.99 M(+2.6%) |
| Dec 2020 | $40.92 M | $40.92 M |
FAQ
- What is Tango Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Tango Therapeutics?
- What is Tango Therapeutics annual current liabilities year-on-year change?
- What is Tango Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Tango Therapeutics?
- What is Tango Therapeutics quarterly current liabilities year-on-year change?
What is Tango Therapeutics annual total current liabilities?
The current annual current liabilities of TNGX is $45.94 M
What is the all time high annual current liabilities for Tango Therapeutics?
Tango Therapeutics all-time high annual total current liabilities is $55.55 M
What is Tango Therapeutics annual current liabilities year-on-year change?
Over the past year, TNGX annual total current liabilities has changed by -$9.61 M (-17.30%)
What is Tango Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TNGX is $37.58 M
What is the all time high quarterly current liabilities for Tango Therapeutics?
Tango Therapeutics all-time high quarterly total current liabilities is $55.55 M
What is Tango Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TNGX quarterly total current liabilities has changed by -$8.36 M (-18.19%)